TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING PSORIASIS AND METHOD FOR PREPARING THE SAME

Abstract

The invention relates to the field of traditional Chinese medicine, in particular to provides traditional Chinese medicine compositions for the treatment of psoriasis, their preparations and their preparation methods. The Chinese medicine compositions of the invention are consisted of 20-80 parts of Rumex madaio, 20-80 parts of Radix sophora flavescens, 10-50 parts of Herba Siphonostegiae, 10-40 parts of Chinese pulsatilla chinensis, and 5-30 parts of Acacia catechu, by weight. The invention also includes the preparation methods of the traditional Chinese medicine compositions and the preparations containing the traditional Chinese medicine compositions and method for preparing the same. The pharmacological experiments and clinical experiments proved that the traditional Chinese medicine compositions of the invention have remarkable curative effects on psoriasis vulgaris, high cure rate, no toxic and side effects of hormones, and is suitable for the characteristics of psoriasis having long-term use due to the long-course of the diseases.

Claims

1. A traditional Chinese medicine composition for treating psoriasis, consisting of: 20-80 parts (w/w) Rumex madaio; and 20-80 parts (w/w) Radix sophora flavescens.

2. A traditional Chinese medicine composition for treating psoriasis, consisting of 20-80 parts (w/w) Rumex madaio, 20-80 parts (w/w) Radix sophora flavescens and 10-50 parts (w/w) Herba Siphonostegiae.

3. A traditional Chinese medicine composition for treating psoriasis, consisting of 20-80 parts (w/w) Rumex madaio, 20-80 parts (w/w) Radix sophora flavescens, 10-50 parts (w/w) Herba Siphonostegiae, 10-40 parts (w/w) Chinese pulsatilla chinensis, and 5-30 parts (w/w) Acacia catechu.

4. The traditional Chinese medicine composition according to claim 3 wherein the Rumex madaio is dry roots of commonly known as Rumex madaio having sixteen varieties of base sources, and includes wild or cultivated medicinal materials and their prepared drug in pieces or processed products; wherein the Radix sophora flavescens is dry roots of the leguminous plant Sophora flavescens Ait., including wild or cultivated medicinal materials and their prepared drug in pieces or processed products; wherein the Herba Siphonostegiae is dry whole herbs of scrophulariae plant Siphonostegia chinensis Benth., including wild or cultivated medicinal materials and their prepared drug in pieces or processed products; wherein the Chinese pulsatilla chinensis is dry roots of ranunculaceae plant Pulsatilla chinensis (Bge.) Regel, including wild or cultivated medicines and their prepared drug in pieces or processed products; and wherein the Acacia catechu is dry decocting paste of peeled branch and trunks of leguminosae plant Acacia catechu (L.f.) Willd., or processed product thereof.

5. A method for preparing the said traditional Chinese medicine compositions according to claim 1, characterized in that, the method is preparing the traditional Chinese medicine compositions according to the preparing process of extracts, in which the preparing process of the extracts comprises the following steps: extracting the extraction solvent is water or 50-100% pharmaceutically ethanol solution; the extraction method comprises soak, reflux via heating, diacolation after maceration, ultrasonic extracting, microwave extracting, boiling or supercritical liquid extracting; wherein the time for soak is preferably 0.5 to 1.0 hours; the extractions times is 2 to 4 times; the time for extraction is 1.0 to 2.0 hours, and the total amount of solvent used for extraction is 15 to 20 L/Kg; filtering by settling separation under atmospheric pressure, pressurization or vacuum filtration, centrifugal separation, or ultrafiltration; concentrating under reduced pressure, thin film concentration, centrifugation, evaporation via thin film evaporator; the concentration temperature is 60 C. or below; and drying by vacuum drying, spray drying, freezing drying or microwave drying.

6. The method for preparing the traditional Chinese medicine compositions according to claim 5, characterized in that, the said method further comprises performing a refining process, and wherein performing said refining process includes refining the extracts obtained according to the following steps: using macroporous adsorption resin wherein the said macroporous resin is selected from non-polar, weak-polar, medium-polar or polar resins, and their model number are AB-8, SP-825, DM-130, X-5, HPD400, HP-20, D101, HPD100, HPD600 or NKA-9; using ion exchange resin wherein the resin is cationic exchange resin; using polyamide chromatography wherein 30-60 mesh polyamide is selected, which is suitable for compositions containing flavonoids; or using membrane separation technology wherein ultrafiltration membrane is used to intercept macromolecular organic impurities and reverse osmosis membrane is used to intercept small molecular impurities.

7. The method for preparing the said traditional Chinese medicine compositions according to claim 5, characterized in that, the method comprises the following steps: preparing the extracts wherein individual components having corresponding weight parts in the composition are obtained respectively, and broken into coarse grains, mixed uniformly, the resulting mixture is immersed in a solvent of water or 50-100% pharmaceutical ethanol at about 40 degrees for about 0.5 to 1 hour, then is extracted for three times by heating refluxing, each extraction time is 1-2 hours and the total amount of solvents is 15-20 (L/kg); the reflux solution is subjected to sedimentation separation under atmospheric pressure, treated by one or two of suction filtration or centrifugation (4000 rpm, 30 min) to obtain the extract solution; solvents the in extract solution are recovered by treatment of one or two selected from evaporation concentration under reduced pressure or film concentration at 60 C. or below to provide a concentrate; and the concentrate is dried under vacuum at 60 C. or below to provide the extracts; the extract is pulverized into fine powder, which is prepared into suitable formulations; preparing refined products, including: refining extracts obtained by using ethanol wherein refining extracts includes firstly includes being treated by water sedimentation, the water-insoluble precipitated after treating is dried under vacuum and stored, the remaining aqueous solution is separated by any one of macroporous adsorption resin columns selected from AB-8, SP-825, or X-5, in which the diameter-length ratio of the resin column is 1:6-1:10, the column is eluted with water at a flow rate of 2-9 BV/h to remove impurities such as saccharides and inorganic salts, and then is gradiently eluted with 5%-100% ethanol at a flow rate of 3-10 BV/h, the eluate is collected, concentrated under reduced pressure, vacuum dried and combined with the water insoluble precipitates to provide the refined products; or refining method of water extracts extracted by water wherein the water extracts are precipitated with several times of ethanol to provide ethanol precipitate and ethanol soluble substance, the macromolecular impurities in the ethanol precipitate are discarded; the water-insoluble substance in the ethanol-soluble portion is dried and stored; the water-insoluble substance is subjected to macroporous resin adsorption or polyamide chromatography to remove small molecular sugars and inorganic salts, or is treated by membrane separation technology to remove impurities; when the impurities are removed by macroporous adsorption resin in which a column having a diameter-length ratio of 1:6 to 1:10 is used, the column is eluted with water at a flow rate of 5-2 BV/h to remove small molecular saccharides and inorganic salts, and then eluted gradiently with 5%-100% ethanol at the flow rate of 3-10 BV/h; the eluate is collected, concentrated under reduced pressure, dried under vacuum, and combined with the dry substance of the water insoluble substance to provide the refined products.

8. Preparations containing the traditional Chinese medicine compositions according to claim 5, or the extracts or refined products thereof, characterized in that, the preparations comprise external preparations or internal preparations, wherein the external preparations include gel, ointment, cream, film coating agent, powder for topical application, lotion, liniment, paste, aerosol, spray or plaster; and wherein the oral preparations include tablet, granule, powder, pill, capsule, syrup, dripping pill, liquid extract, extract or medicinal tea.

9. The preparations according to claim 8, characterized in that, in the external preparations, the adjuvant of the water-soluble matrix mainly used in the said gel, ointment or cream comprises: carbomer, glycerin gelatin, starch glycerin, cellulose derivative, polyethylene glycol, alginate, gum tragacanth, gelatin or any combination thereof; preferably the carbomer gel matrix; or comprises water-insoluble matrix in combination with water-soluble matrix; the said matrix of the film coating agent includes polyvinyl alcohol (PVA), polyvinyl formal-acetal, polyvinyl pyrrolidone, carboxymethyl chitosan or carbomer, or any combination thereof; and the plasticizer includes glycerol, propylene glycol or dibutyl phthalate, or any combination thereof.

10. The method for preparing the traditional Chinese medicine preparations according to claim 8, characterized in that: the preparation of the said gel with the water-soluble matrix comprises the following steps: preparing the composition or the extracts or refined products of the traditional Chinese medicine compositions by using the raw material drug, and pulverizing the appropriate amount of the raw material drug into fine powder; wherein the appropriate amount of carbomer is weighted, and immersed in distilled water for 24 hours until it is completely swollen, to provide 2%-3% carbomer transparent gel; transferred to a blender for full process stirring, and triethanolamine is dropped to adjust the pH value to 3.5-4; or the pH value of the carbomer is adjusted firstly or lately; another fine power of the extracts or refined products is added in batches, or dissolved in propylene glycol and ethanol and then added to the carbomer gel in batches and stirred evenly; the fine powder of preservative ethylparaben is dissolved in propylene glycol by ultrasound, and added in the mixture, then humectant glycerol, antioxidant sodium thiosulfate, and transdermal absorption agent laurocapram, are added and stirred evenly; triethanolamine is added to the mixture to adjust the pH to 7 after the mixture is stirred uniformly, then said mixture is uniformly stirred in the same direction until a viscous gel is formed, to provide the gel of the extracts or the refined products; the content of the extracts in the preparations using the as the raw material drug are 20% to 30%; and the content of the refined products in the preparations using the refined products as the raw material drug are 10% to 20%; preparing the said skin coating, comprising: PVA (124, 1750, or 1788) or polyvinyl formal-acetal water-soluble film-forming materials are added with purified water or 80% ethanol so as to be soaked in a water bath at 80 C. to fully swell into a light yellow semi-liquid liquid; transferred to a blender for full process stirring, and then added with appropriate amount of diethyl phthalate plasticizer and mixed evenly to provide liquid; the compositions or the extracts or refined products of the traditional Chinese medicine compositions prepared are used as a raw material drug, and pulverized into a very fine powder, and dissolved in propylene glycol-ethanol; added to the liquid in batches, and uniformly mixed; and then added ethylparaben preservative dissolved in propylene glycol, moisturizing agent, percolating agent, and antioxidant are added to the mixture, stirred uniformly, stood until no bubbles, loaded into a glass bottle in divided dosages, and sealed and obtained; preparing the said ointment or cream, comprising: the compositions or the extracts or refined products of the traditional Chinese medicine compositions are used as the raw material drug, pulverized into extremely fine powder, and the appropriate amount of propylene glycol-ethanol is added to dissolve said very fine powder and standby for use; the oil phase matrix selected from stearic acid, glyceryl monostearate, liquid paraffin, azone and the aqueous phase matrix selected from glycerin, water-soluble lanolin, and ethylparaben are respectively heated to 80 C., and the aqueous phase matrix is added to the oil-phase matrix under stirring from blender; then is cooled to 40 C., the solutions of raw material drug are added in batches and continually stirred until completely uniform; or, regarding patients suffering from psoriasis with erosion wound, for the purpose of being more conducive to absorbing tissue exudate, when water-soluble matrix is used, glycerin gelatin, a cellulose derivative (CMC-Na), polyethylene glycol are selected; and prepared, the preparation including: selecting high viscosity CMC-Na, and mixed well with glycerol, adding the proper amount of purified water, mixing evenly, stand it until it is dissolved into gel, and then adding the above raw material drug solution, aqueous solution of Ethylparaben, transdermal absorbent and antioxidant, and continuously stirring until it is completely uniform and obtained; preparing tablets, comprising: the compositions or the extracts or refined products of the traditional Chinese medicine compositions are used as the raw material drug, and pulverized into fine powder of 80-160 mesh; added to the appropriate excipients, granulated by using ethanol as wetting agent, dried under reduced pressure (50-70 C.), tableted and coated and obtained; preparing granules, comprising: the compositions or the extracts or refined products of the traditional Chinese medicine compositions are used as the raw material drug, pulverized into fine powder of 80-160 mesh; and oligosaccharide or dextrin is used as the adjuvants for forming, and granulated by the technologies of spray drying and dry granulation; preparing powders, comprising: the compositions or the extracts or refined products of the traditional Chinese medicine compositions are used as the raw material drug, pulverized into fine powder of 80-160 mesh, sieved and mixed evenly, and obtained; or preparing capsules, comprising: the compositions or the extracts or refined products of the traditional Chinese medicine compositions are used as the raw material drug, pulverized it into fine powder of 80-160 mesh, added with adjuvants such as 1-2% methyl cellulose, poly-silicone or hydroxyethyl cellulose to make the powders have good fluidity and ensure that the powders is quickly and accurately filled into gelatin hard capsules; the filling process of the drugs is carried out in the environment of about 25 C. and relative humidity of 35%-45%.

11. The Chinese medicine composition according to claim 1, wherein the composition consists of 35-65 parts (w/w) Rumex madaio and 35-65 parts (w/w) Radix sophora flavescens.

12. The Chinese medicine composition according to claim 1, wherein the composition consist of 30-50 parts (w/w) Rumex madaio and 30-50 parts (w/w) Radix sophora flavescens.

13. The Chinese medicine composition according to claim 2, wherein the composition consists of 20-50 parts (w/w) Rumex madaio, 20-50 parts (w/w) Radix sophora flavescens, and 15-40 parts (w/w) Herba Siphonostegiae.

14. The Chinese medicine composition according to claim 2, wherein the composition consists of 25-45 parts (w/w) Rumex madai, 25-45 parts (w/w) Radix sophora flavescens, and 20-35 parts (w/w) Herba Siphonostegiae.

15. The Chinese medicine composition according to claim 3, wherein the composition consists of 20-50 parts (w/w) Rumex madaio, 20-50 parts (w/w) Radix sophora flavescens, 15-40 parts (w/w) Herba Siphonostegiae, 10-40 parts (w/w) Chinese pulsatilla chinensis, and 10-30 parts (w/w) Acacia catechu.

16. The Chinese medicine composition according to claim 3, wherein the composition consists of 20-40 parts (w/w) Rumex madaio, 20-40 parts (w/w) Radix sophora flavescens, 15-30 parts (w/w) Herba Siphonostegiae, 15-30 parts (w/w) Chinese pulsatilla chinensis, and 10-20 parts (w/w) Acacia catechu.

17. The Chinese medicine composition according to claim 3, wherein the composition consist of 25-35 parts (w/w) Rumex madaio, 25-35 parts (w/w) Radix sophora flavescens, 15-25 parts (w/w) Herba Siphonostegiae, 15-25 parts (w/w) Chinese pulsatilla chinensis, and 10-15 parts (w/w) Acacia catechu.

18. The Chinese medicine composition according to claim 4, wherein Rumex madaio is selected from dry roots of varieties of base sources of R.patientia, R.crispus, R.nepalensis, R.japonicus, R.dentatus, and/or R.obtosifolius.

Description

DRAWINGS

[0063] FIG. 1 is a graph showing the results of observation under light microscopy after treatment of the pharmaceutical compositions and the control preparations of the present invention.

DETAILED DESCRIPTION

[0064] The present invention is further illustrated by the following examples and experimental examples, but the invention is not to be limited.

Preparation of Traditional Chinese Medicine Compositions

Example 1

[0065] Components (Parts by Weight): Rumex madaio 700 g, Radix sophora flavescens 300 g;

[0066] Method:

[0067] The above two Components were separately broken and well mixed based on said weight, and refluxed with 50% pharmaceutical ethanol having 8 times, 6 times, 6 times of total weight of the components to extract for 3 times, in which the first extraction was 2 hours, and each of the 2.sup.nd and 3.sup.rd extraction was 1.5 hours. The three extract solutions were combined, separated by sedimentation, and filtered with several layers of gauze, the turbid part at the bottom was centrifuged, and the extract solution was concentrated to a thick paste at 60 C. or below under reduced pressure, and the thick paste was dried in a vacuum dryer to obtain the extracts.

Example 2

[0068] Components (Parts by Weight): Rumex madaio 600 g, Radix sophora flavescens 400 g

[0069] Method:

[0070] The above two Components were separately broken, well mixed according to the weights, and refluxed with 70% pharmaceutical ethanol having 8 times, 7 times and 5 times of total weight of the components to extract for 3 times, in which the 1.sup.st extraction was 2 hours, and each of the 2.sup.nd and 3.sup.rd extraction was 1.5 hours. The three extract solutions were combined, separated by sedimentation, and filtered with nylon cloth. The turbid part at the bottom was centrifuged to separate, and the extract solution was concentrated to an alcohol-free thick paste at 60 C. or below under reduced pressure, the thick paste was repeatedly dissolved in water, the water-insoluble portion was dried and then stored; and the water-soluble portion was separated by AB-8 macroporous adsorption resin which the diameter-length ratio of the resin column is 1:8, and the column was first eluted with water at 4-8 BV/h, until the impurities such as saccharides were washed away and discarded. The column was further gradiently eluted with 5%-80% ethanol at a flow rate of 2-10 BV/h, finally the adsorbates in the column was washed away with 95%-100% ethanol, and the eluate was collected, concentrated under reduced pressure, dried under vacuum and combined with the aforementioned water-insoluble dry matter to provide the refined products. The refined products can be used as a raw material drug for various external or internal preparations.

Example 3

[0071] Components (Parts by Weight): Rumex madaio 350 g, Radix sophora flavescens 650 g

[0072] Method:

[0073] The above two components were separately broken, well mixed according to the weight, and refluxed with purified water having 8 times, 6 times, 6 times of total weight of the components to extract for 3 times, in which the 1.sup.st extraction was 2 hours, and each of the 2.sup.nd and 3.sup.rd extraction was 1.5 hours. The three extract solutions were combined, separated by sedimentation, and filtered, the extract solution was concentrated to a thick paste at 60 C. or below under reduced pressure, and the thick paste was dried in a vacuum dryer to obtain the extracts.

Example 4

[0074] Components (Parts by Weight): Rumex madaio 300 g, Radix sophora flavescens 450 g, Herba Siphonostegiae 250 g

[0075] Method:

[0076] The above three components were separately broken, and well mixed according to the weight, and refluxed with 60% pharmaceutical ethanol having 8 times, 7 times, 5 times of total weight of the components to extract for 3 times, in which the extraction time were 2 hours, 1.5 hours, and 1 hour, respectively, the three extract solution were combined, separated by sedimentation, and filtered with several layers of gauze, the turbid part at the bottom was centrifuged, and the extract solution was concentrated to a thick paste at 60 C. or below under reduced pressure, and the thick paste was dried in a vacuum dryer to obtain the extracts.

Example 5

[0077] Components (Parts by Weight): Rumex madaio 400 g, Radix sophora flavescens 300 g, Herba Siphonostegiae 200 g

[0078] Method:

[0079] The above three components were separately broken, and well mixed according to the weight parts, pulverized into fine powder, sieved, mixed, pelletized with 20-30 g of refined honey and an appropriate amount of water per 100 g of powder, and dried, to make water-honeyed pill.

Example 6

[0080] Components (parts by weight): Rumex madaio 350 g, Radix sophora flavescens 350 g, Herba Siphonostegiae 300 g

[0081] Method:

[0082] The above three components were separately broken, well mixed according to the weight parts, and refluxed with 70% pharmaceutical ethanol having 8 times, 6 times, 6 times of total weight of the components to extract for 3 times, in which the 1.sup.st extraction was 2 hours, and each of the 2.sup.nd and 3.sup.rd extraction was 1.5 hours. The three extract solutions were combined, separated by sedimentation, and filtered, the extract solution was concentrated to a thick paste at 60 C. or below under reduced pressure. The thick paste was repeatedly dissolved in water, the water-insoluble portion was dried and then stored in another vessel; and the water-soluble portion was subjected to chromatography on a polyamide column (the diameter-length ratio of the resin column is 1:8), the column was firstly eluted with water at 8-2 BV/h, and the eluate was real-time detected until there was no saccharide detected, and discarded. The column was further gradiently eluted with 5%-80% pharmaceutical ethanol, finally, the adsorbate in the column was washed away with 95%-100% ethanol, and the eluate was collected, concentrated at 60 C. or below under reduced pressure, vacuum dried at 60 C. or below and combined with the aforementioned water-insoluble dry matter to provide the refined products.

Example 7

[0083] Components (Parts by Weight): Rumex madaio 350 g, Radix sophora flavescens 250 g, Herba Siphonostegiae 150 g, Chinese pulsatilla chinensis 150 g, Acacia catechu 100 g

[0084] Method:

[0085] The above five components were broken respectively, and mixed according to the weight parts, and refluxed with 70% pharmaceutical ethanol having 8 times, 6 times and 6 times of total weight of the components to extract for 3 times, in which the 1.sup.st extraction was 2 hours, and each of the 2.sup.nd and 3.sup.rd extraction was 1.5 hours. The three extract solutions were combined and separated by sedimentation and filtered, and the extract solution was concentrated at 60 C. or below under reduced pressure to free of alcohol, precipitated with several times amount of purified water to obtain water-precipitation substance and water-soluble substance. The water-precipitation substance was vacuum dried and preserved; and the water-soluble substance was passed through the AB-8 or SP-825 macroporous adsorption resin column having a diameter-length ratio of 1:6 to 1:10. The column was firstly eluted with water at a flow rate of 2-9 BV/h, so as to remove impurities such as saccharide and inorganic salts. The column was then gradiently eluted with 5%-100% ethanol at a flow rate of 3-10 BV/h, the eluate was collected, concentrated under reduced pressure, dried under vacuum and combined with the aforementioned water-precipitation substance to obtain the refined products.

Example 8

[0086] Components (Parts by Weight): Rumex madaio 300 g, Radix sophora flavescens 300 g, Herba Siphonostegiae 200 g, Chinese pulsatilla chinensis 150 g, Acacia catechu 50 g

[0087] Method:

[0088] The above five components were broken respectively, and well mixed according to the weight parts, refluxed with purified water having 8 times, 6 times and 6 times total weight of the components to extract for 3 times, in which the extraction time was 2 hours, 1.5 hours, and 1.5 hours, respectively, the extracts were combined and separated by sedimentation, and then filtered with several layers of gauze, the turbid part at the bottom was centrifuged, and the extract was concentrated at 60 C. or below under reduced pressure to a thick paste, the thick paste was dried in a vacuum dryer to provide the extracts.

Example 9

[0089] Components (Parts by Weight): Rumex madaio 250 g, Radix sophora flavescens 250 g, Herba Siphonostegiae 200 g, Chinese pulsatilla chinensis 200 g, Acacia catechu 100 g

[0090] Method:

[0091] The above five components were separately broken, and well mixed according to the weight parts, refluxed with 80% pharmaceutical ethanol having 8 times, 6 times and 6 times of total weight of the components to extract for three times, in which the extraction time was 2 hours, 1.5 hours, and 1.0 hour respectively, the three extracts were combined, and separated by sedimentation, and then filtered with several layers of gauze, the turbid part at the bottom was centrifuged, and the extract was concentrated at 60 C. or below under reduced pressure to a thick paste, the thick paste was dried in a vacuum dryer to provide the extracts

Preparation of the Preparation

Example 10 Preparation of Gel (Two Components)

[0092] Raw Material Preparation:

[0093] 30 g the raw material drug (extracts) from Example 1 were pulverized and passed through a 100 mesh sieve.

[0094] Preparation of the Preparations:

[0095] 2 g carbopol-974 was selected as the gel matrix, and in which 50 ml of purified water was added, and swelled for 24 hours, then were adjusted pH value to 4 with triethanolamine, and evenly stirred with blender. 30 g of the extract powder from Example 1 was dissolved in 40 ml of propylene glycol, 5 ml of glycerin and 5 ml of ethanol, and added into the above carbomer gel matrix under stirring. 4% transdermal absorbent laurocapam and 3 ethylparaben preservative (finely ground), and 3 sodium thiosulfate antioxidant were added under stirring, the pH value was adjusted to 7 by triethanolamine, and uniformly stirred in the same direction to prepare a uniform and fine hydrophilic gel.

Example 11 Preparation of Gel (Three Components)

[0096] Raw Material of the Preparations:

[0097] 10 g of the raw material refined products from Example 6 was pulverized and passed through a 100 mesh sieve.

[0098] Preparation of the Preparations:

[0099] 3 g of sodium alginate was selected, and to which 50 ml purified water was added, and swelled to a viscous gel. The fine powder of refined products was dissolved in 35 ml of propylene glycol and 10 ml of glycerin, and stirred evenly in a mixer; then 3%, finely ground ethylparaben preservative ultrasonically dissolved in 5 ml of propylene glycol were added, further 3% laurocapam transdermal absorbent was added, and stirred evenly in the same direction, then the viscous gel of alginate was slowly added and mixed uniformity under even stirring in a mixer.

Example 12 Preparation of Gel (Five Components)

[0100] Raw Material of the Preparations:

[0101] 30 g of the extracts from Example 8 was pulverized and passed through a 120 mesh sieve.

[0102] Preparation of the Preparations:

[0103] 30 g of above raw material drug powder, 2 ml of polysorbate 80, 10 g of polyethylene glycol 400 and 40 ml of propylene glycol were mixed, heated to 80 C., in order to form a transparent solution, stirred evenly by a blender, and then all of 3 preservatives Ethylparaben and 3% of laurocapam were added under stirring. Further, 1 g of xanthan gum and 2 g of sodium carboxymethyl cellulose were dissolved in 45 ml of water, heated to 85 C. to make a matrix solution, gradually added to the above drug solution under stirring, finally added water to reach 100 ml, and cooled at room temperature to provide a translucent gel.

Example 13 Preparation of Film Coating Agent

[0104] Raw Material of the Preparations:

[0105] The refined products from Example 2 was used as a raw material drug, and passed through a 120 mesh sieve.

[0106] Preparation of the Preparations:

[0107] PVA17-88 (concentration: 10%) and carbopol-940 were placed in two beakers respectively. PVA17-88 was swollen in 5 times weight of purified water, and carbopol-940 was swollen in 60% ethanol under magnetic stirring, then they were respectively swelled into mucilage in the water bath of 90 C. (until there is no block visible), and filtered with gauze, standby. Glycerin, Tween-80 and ethyl 4-hydroxybenzoate were added into ethanol and stirred to dissolve, added to the fine powder of the above raw material in batches under stirring, stirred evenly, then added the mucilage of PVA17-88 and carbopol-940, stirred evenly, added ethanol and purified water to full amount, added triethanolamine solution to adjust the pH value to 7, and ultrasonically shaked until there is no bubbles.

Example 14 Preparation of Tablets

[0108] Raw Material of the Preparations:

[0109] the extracts from Example 8 was used as a raw material drug.

[0110] Method of the Preparations:

[0111] the dried extracts were pulverized to 100-120 mesh, evenly mixed with an appropriate amount of starch, granulated, dried and then tableted to provide tablets.

Example 15 Preparation of Granules

[0112] Raw Material of Preparations:

[0113] the extracts from Example 4 was used as raw material drug.

[0114] Preparation Methods:

[0115] the dried extracts from Example 4 is pulverized and passed through an 80 mesh sieve, to provide a dry extract powders and standby; the said dry extract powders and dextrin were mixed in a weight ratio of 2:1, added 85% ethanol as a wetting agent at a weight of 30% of total weight of the said dry powders and dextrin, further added stevioside at a weight of 2% of total weight of the said dry powder and dextrin, processed to soft material, sieved through 16 mesh, granulated, dried at 50 C., processed granulation, and split charged to provide finished products of granulates.

[0116] Test 1. Comparative Study of the Therapeutic Effects of Samples 1-4 on Experimental Psoriasis Model Via Topical Administration

[0117] Preparation of samples: the dried powders of the four samples 1-4 (each sample comprising the specific components and proportion thereof, please see Table 1) were weighed, formulated into thick paste with propylene glycol before the experiment, and to which the appropriate amount of transdermal absorption promoter was added.

TABLE-US-00001 TABLE 1 components and proportions in the tested samples 1-4 (refined substance) Rsdix Chinese Rumex sophora Herba pulsatilla Acacia madaio flavescens Siphonostegiae chinensis catechu Name of samples (Parts) (Parts) (Parts) (Parts) (Parts) Sample 1 100 (Refined products from Rumex madaio) Sample 2 60 40 (Refined products from Example 2) Sample 3 35 35 30 (Refined products from Example 6) Sample 4 35 25 15 15 10 (Refined products from Example 7 ) Note: 1) preparation method of Sample 1 is the same with Sample 2. 2) Sample 1 is acted as a control of single drug from Rumex madaio.

[0118] 1.1 Effect of Samples 1-4 on Psoriasis-Like Skin Lesion Model of Guinea Pig Auricular Skin Induced by Propranolol Hydrochloride

[0119] Sixty guinea pigs (weight 300-350 g), half male and half female, according to sex and weight, they were randomly divided into the blank control groups which comprise 10 guinea pigs and model group which comprise 50 guinea pigs. Blank control group were not subjected to any treatment. In model groups, each guinea pig was quantitatively smeared with 5% propranolol hydrochloride emulsion on its back skin of left auricle by 1 ml syringe, 0.1 ml/cm.sup.2, twice a day (the interval is more than 6 hours), continued for 2 weeks. The skin samples of the auricle of two guinea pigs in the normal group and two in the model group were removed and obtained by operation in 24 hours after the last model establishment. The skin samples were fixed with 10% formaldehyde, stained with HE and observed under light microscope to evaluate the quality of the model.

[0120] 48 guinea pigs in the model group were divided into 6 groups according to thickness of the auricle at the model side, 8 in each group. The experiment was divided into model group, Halometasone ointment active control group and sample 1-4 groups. Each sample group and positive control group were smeared with drug twice a day (the interval is more than 6 hours), continued for 2 weeks. The blank control was not subjected to any of treatment, the model group was administrated the same volume of propylene glycol. The thickness of the auricle was measured by vernier caliper every other day during the administration period, the hardness, skin color and scales change of the auricle were observed with naked eyes. After 2 weeks of administration, the skin of the left auricle of guinea pigs (on the administration side) was obtained by operation, fixed with 10% formaldehyde, embedded in paraffin and stained with HE, the changes of stratum corneum, stratum granulosum, stratum spinosm, stratum basale and lamina propria of the auricle skin were observed under light microscope. Significant difference between samples 2-3 and Rumex madaio (sample 1) were compared, after statistical treatment.

[0121] Result:

[0122] it was observed by the naked eye that the thickness of auricle from samples 1, 2, 3, 4 and positive Halometasone ointment group had become thinner and softer in varying degrees, the color tended to be normal, and the silver-white scales gradually disappeared on the 7th day after treatment. Compared with the model group, the thickness of auricle from each sample decreased significantly after 14 days of treatment. The results are shown in Table 1-1.

TABLE-US-00002 TABLE 1 Comparison of the effects of samples 1-4 groups on the auricle thickness of guinea pigs (X + SD, n = 8) Administration Auricular thickness Group site (mm) Blank control 0.54 0.01**** Model control back of auricle 1.48 0.39 Positive Halometasone ointment back of auricle 0.51 0.09**** Sample 1 back of auricle 1.12 0.39* Sample 2 back of auricle 0.67 0.26**# Sample 3 back of auricle 0.76 0.22**# Sample 4 back of auricle 0.81 0.30** Note: (1) Compared with model control group, *P < 0.05, **P < 0.01, ***P < 0.005, **P < 0.001; (2) Compared with sample 1 group, #P < 0.05; the same below.

[0123] In table 1-1, it is showed that the auricle thickness of guinea pig in propranolol hydrochloride model group was significantly higher than blank control group (P<0.001), suggested that the model of auricle psoriasis-like skin lesion of guinea pig induced by propranolol hydrochloride was successful. Compared with the model of control group, samples 1, 2, 3 and 4 could significantly reduce the auricle thickness of model guinea pigs (P<0.05 or P<0.01); effect of samples 2 and 3 was significantly better than that of sample 1 (P<0.05); compared with sample 1, sample 4 showed a certain trend of effect, but there was no statistical difference (P>0.05).

[0124] Under light microscopy, auricle skins of normal guinea pig are a complete and homogeneous stratum corneum; the stratum granulosum is linear with obvious black granules on both sides, has about 1-3 layers; the stratum spinosm is mostly angular cells, and has about 4-6 layers; the stratum basale is a single layer of columnar cells, in which mitotic phase is reduced; the lamina propria is loose connective tissue; there is no significant abnormality in the hair follicles. In model group, cornification of stratum corneum was incomplete or excessive, stratum spinosm became thicker, and has about 5-8 layers, of which of the nuclei were vacuolated; mitotic phase of stratum basale decreased, and there were more black-brown granulosa cells in cytoplasm of stratum basale in partial sections; congestion of lamina propria was found in individual sections. In each sample group, stratum corneum was relatively complete, and only individual animals showed uneven thickness or loose network; the stratum granulosum had more black-brown granules; the stratum spinosm became thinner, and has about 3-7 layers, with about cell nucleus vacuolated (limitation); the mitotic phase of stratum basale cell decreased, no obvious brown granules were observed, and no obvious abnormalities were observed in submucosal hair follicles. The results suggest that samples 1-4 can significantly inhibit the psoriasis-like lesions of guinea pig auricle induced by propranolol hydrochloride, and indicated that samples 1-4 can significantly improve the pathological lesions of guinea pig auricle. The therapeutic effect of samples 2-4 was obviously better than sample 1. The specific results are shown in FIG. 1.

[0125] 1.2 Effect on Scaly Epidermis on the Tails of Mice

[0126] Sixty healthy ICR mice (weight 18-22 g), half male and half female, were balancedly and randomly divided into 6 groups according to gender and body mass, each group has 10 mice. They were divided into matrix control group, positive control clobetasone propionate ointment group (0.02%) and samples 1-4 group. The tail skin of the mice in each group was smeared with drug twice a day (the interval is more than 6 hours). After 14 days of continuous administration, the mice were executed. The back epidermis about 1.5 cm from the tail root was taken and fixed with 10% formaldehyde, tissue sections were made routinely and HE stained. The changes of stratum corneum, stratum granulosum, stratum spinosm, dermis and hair follicle of mouse tail epidermis were observed under optical microscope. The number of scales with stratum granulosum formation in 100 scales was counted (where there are rows of granular layers on the scales epidermis between the orifices of two hair follicles, which will be counted as the scales with the formed granular layers). Histopathological examination showed that there were fewer granulosa cells in the tail epidermis of normal mice and the structure was normal. In the positive group, the stratum corneum was uneven, and some segments disappeared. There were many small particles in stratum granulosum, and the stratum spinosm was more 4-5 layers than the original. Samples 1-4, stratum corneum disappeared in some sections, more granules were found in the stratum granulosum, and stratum spinosm was more 3-4 layers than the original. The results showed that the formation of stratum granulosum of tail scales epidermal of mice in samples 1-4 and positive control groups were obviously induced after 2 weeks of external administration, it is suggested that each sample group had a good therapeutic effect on the main pathological manifestations such as imperfect cornification. The effect of samples 2-4 groups were more obvious than sample 1. The results are shown in Table 1-2.

TABLE-US-00003 TABLE 1-2 Effect of samples 1-4 on the formation of stratum granulosum in scale epidermis of mice tail (n = 10) Number of scales Administration with stratum granulosum Group site per 100 scales Matrix control group Tail 11.2 3.4 Clobetasone propionate Tail 21.5 6.1*** ointment Sample 1 Tail 15.0 3.2* Sample 2 Tail 20.9 3.4**# Sample 3 Tail 19.9 3.1**# Sample 4 Tail 20.1 3.8**#

[0127] 1.3 Inhibitory Effect on Auricular Inflammation in Mice Induced by Croton Oil

[0128] In severe psoriasis patients, because of the long-term skin lesions, also there are inflammation phenomena in skin lesions, such as redness, swelling, heat, pain and so on. Therefore, the inhibition of exudative inflammation by samples 1-4 was observed in the test, the comparison study over sample 1 also was conducted.

[0129] 70 Kunming mice (weight 18-22 g), half male and half female. According to body weight, they were randomly divided into 7 groups, with 10 mice in each group. They were divided into blank control group, inflammation model group, positive Halometasone ointment group and samples 1-4 groups. Animals in each group were smeared with drug on the back of the right auricle of mice (left ear as self-control) daily, once a day, continued for 7 days. Auricle in the blank control group was not subjected to any treatment, and the croton oil model group was administrated drug matrix propylene glycol. One hour after the last administration, the subjects were washed with warm water. Except the blank control group, the right ears of mice in the remaining groups were smeared with 2% croton oil at 50 ul/mouse via syringes on the front and back sides respectively. Each group was smeared once again after three hours. The mice were executed one hour after the last administration, their ears were cut off, the ears slices were cut using a drill which has a diameter of 8 mm. The ears were weighed accurately and the weight difference between the two ears of its own is taken as the swelling value. After statistical treatment, t-test was carried out between groups to compare the significance of anti-inflammatory effect. The results are shown in tables 1-3.

TABLE-US-00004 TABLE 1-3 Inhibitory effects of samples 1-4 on auricular inflammation in mice induced by croton oil (X + SD, n = 10) Administration Swelling value Inhibitation Group site (mg) (%) Blank control 1.03 0.07 Model control back of auricle 38.56 9.01 Positive back of auricle 8.25 1.33**** 78.60 Halometasone ointment Sample 1 back of auricle 23.59 6.72* 38.82 Sample 2 back of auricle 13.47 4.39***## 65.07 Sample 3 back of auricle 16.46 5.31**# 58.05 Sample 4 back of auricle 15.03 5.86***# 61.02

[0130] The results showed that samples 1-4 had significant inhibitory effect on exudative inflammation of mouse auricles induced by croton oil (P<0.05, P<0.01 or P<0.005 compared with model group), and the anti-inflammatory effects of samples 2, 3 and 4 were stronger than that of sample 1. Sample 2>Sample 3>Sample 4>Sample 1 in terms of the intensity of anti-inflammatory effect.

[0131] In summary, all the samples of the compositions of the present invention show obvious anti-psoriasis effect, and the effect of samples 2-4 are approximately similar.

[0132] Test 2. Comparative Study on the Treatment Effects of Samples 1-4 on Experimental Psoriasis Model Via Oral Administration

[0133] Sample Preparation:

[0134] the dry powders of refined products of samples 1-4 in table 1 was selected and prepared into uniform suspension solution with purified water.

[0135] 2.1 the Therapeutic Effect of Samples 1-4 on Psoriasis-Like Lesions of Auricle Skin in Guinea Pigs Induced by Propranolol Hydrochloride by Gavage Administration

[0136] Sixty guinea pigs (weight is similar with experiment 1.1), the method of modeling and grouping were the same as experiment 1.1. YinXieLing was used as a positive control drug in this experiment via oral administration. During the administration period, the model group is not subjected to any treatment, which is acted as natural recovery control group of the skin lesion model; and each sample group was administrated intragastrically once a day, 0.333 ml/100 g body weight, continued for two weeks, during the administration period, the auricle thickness of each group was measured with vernier caliper every other day, and the color and hardness changes of auricle epidermis were observed. On the 14th day after administration, the skin of the left auricle of guinea pigs was dissected, fixed with 10% formaldehyde, paraffin-embedded, and HE stained. The changes of stratum corneum, stratum granulosum, stratum granulosum, stratum basale and lamina propria of the auricle skin were observed under light microscope.

[0137] Result:

[0138] it is observed by naked eye that the auricle thickness of guinea pigs in sample 1-4 and positive drug YinXieLing group became thinner and softer in varying degrees in 7 days after administration, and the skin color of guinea pigs become better than model group. It is observed by naked eye that the auricle thickness of each tested drug groups and YinXieLing group were significantly declined than that of model group in 14 days after administration of sample 1-4 and positive drug groups (see Table 2-1). It was showed by histopathological examination that the skin of the auricle in the blank control group was normal; extensive or focal parakeratosis could be observed on the auricle of the model group, accompanied by attenuation or disappearance of stratum granulosum. Most of the animals had the characteristics of stratum spinosm thickening, prolongation of epidermal apophysis, infiltration of dermal mononuclear and poly-morphonuclear cells, and telangiectasis. However, samples 1-3 showed significant improvement compared with model groups, and it was showed that cornification was relieved, inflammatory cell infiltration was reduced, and epidermis become thinner. The results of examination via light microscopy showed that blank control group and model control group were basically the same as those in experiment 1.1. The auricle thickness of guinea pigs in sample 1-4 groups was significantly lower than model group (P<0.01, P<0.005 or P<0.001). However, there was no statistical difference between samples 2-4 and sample 1. The results are shown in Table 2-1.

TABLE-US-00005 TABLE 2-1 Effect of samples 1-4 on psoriasis-like auricular lesion induced by propranolol hydrochloride in guinea pigs via intragastrical administration (X + SD, n = 8) Dosage (g raw Route of Auricule thickness Group drug/kg) administration (mm) Blank control Purified water i.g 0.56 0.11**** Model control Purified water i.g 1.51 0.38 YinXieLing 10 i.g 0.68 0.39** Sample 1 10 i.g 0.92 0.35** Sample 2 10 i.g 0.78 0.39*** Sample 3 10 i.g 0.65 0.38*** Sample 4 10 i.g 0.60 0.30**** Note: Compared with model control group, *P < 0.05, **P < 0.01, ***P < 0.005, **P < 0.001, the same as below.

[0139] 2.2 Effect of Samples 1-4 on the Scale Epidermis on Tails of Mice Via Intragastrical Administration

[0140] Sixty ICR mice (weight 18-22 g), half male and half female. Except that the positive control drug was changed to YinXieLing, the animal grouping was the same as experiment 1.2. Animals in each group were administrated orally once a day, continued for 14 days. The mice were executed in 24 hours after the last administration. The back epidermis about 1.5 cm away from the tail root was taken and carried out the routine tissue sections and HE staining. The changes of stratum corneum, stratum granulosum, stratum spinosm, the dermis and hair follicle of mouse tail epidermis were observed by optical microscope. The number of scales with stratum granulosum formation in 100 scales was counted. The results showed that there was a natural lack of stratum granulosum in the scaly epidermis of normal mice, keratinocytes in stratum corneum of the scaly epidermis of mice tail retained nuclei, while granulosa cells in the stratum granulosum were absent. There were only a few granulosa cells in the hair follicle, and the epidermis was thinner. the tested substance i.e. Samples 1, 2, 3 and 4 had obvious promoting effects on the formation of epidermal stratum granulosum of mouse tail scales (P<0.05 or P<0.01 compared with the blank control group). These results suggest that samples 1-4 had obvious therapeutic effect on the main pathological manifestations of tail such as cornification incompleteness etc. in mice, and the effect of samples 2 and 3 is better than samples 1 and 4. The results are shown in Table 2-2.

TABLE-US-00006 TABLE 2-2 Effect of samples 1-4 on the formation of stratum granulosum in the tail epidermis of mice via intragastrical administration (X + sd, n = 10) Number of scales Dosage which having stratum (g raw Route of granulosum formation Group drug/kg) administration per 100 scales Solvent control i.g 11.9 3.6 group YinXieLing 15.0 i.g 23.5 7.21*** Sample 1 15.0 i.g 15.8 4.6* Sample 2 15.0 i.g 19.9 6.4** Sample 3 15.0 i.g 19.7 6.1** Sample 4 15.0 i.g 15.9 4.7*

[0141] 2.3 Anti-Inflammatory Effect of Samples 1-4 on Auricular Inflammation in Mice Induced by Croton Oil

[0142] 70 Kunming male mice (weight 18-22 g) were grouped according to the same way in experiment 1.3. Each groups were administrated intragastrically every day, continued for 7 days. One hour after the last administration, except for the blank control group, the remaining groups were smeared with 50 UL 2% of croton oil with syringes on the front and back sides of mice ears, three hours later, each group was administrated once again. One hour after the last administration, the mice were executed, their ears were cut off, and the ear slices were made with a perforator with 8 mm diameter, weighed accurately, and the difference between the two ears of its own was taken as the swelling value. After statistical treatment, t-test was carried out among groups to compare the significance of anti-inflammatory effect. The results are shown in Table 2-3.

TABLE-US-00007 TABLE 2-3 effects of samples 1-4 on auricular inflammation in mice induced by croton oil via intragastrical administration (X + SD, n = 10) Inhibition Dosage of inflam- (g raw Route of Swelling value mation Group drug/kg) administration (mg) (%) Blank i.g 1.63 0.05**** control Model i.g 33.11 9.87 control YinXieLing 15.0 i.g 17.32 5.33**** 47.69 Sample 1 15.0 i.g 23.78 6.72* 28.18 Sample 2 15.0 i.g 18.47 6.19** 44.22 Sample 3 15.0 i.g 19.39 5.87*** 41.44 Sample 4 15.0 i.g 16.25 5.06***# 50.92

[0143] Table 2-3 showed that samples 1-4 were intragastrically administrated for 7 days, and have a significant inhibitory action on inflammation of mice auricle induced by croton oil. (P<0.05, P<0.01 or P<0.005). Compared with Sample 1, P<0.05 in sample 4, the intensity of anti-inflammatory effect of each sample was sample 4>sample 2>sample 3>sample 1.